Spotlight On ALK+ mNSCLC
ALK+ metastatic non-small cell lung cancer (mNSCLC) is a distinct subtype of lung cancer driven by alterations in the anaplastic lymphoma kinase (ALK) gene. While advances in precision medicine have transformed treatment options and outcomes, patients and healthcare professionals continue to face important questions around diagnosis, treatment selection, disease monitoring, resistance, and long-term management.
Here to help shed light on those key questions is our Spotlight On ALK+ Metastatic Non-Small Cell Lung Cancer series, where you’ll find expert insights on the latest clinical insights, evolving treatment landscape, and real-world care considerations.
1-12 of 12
From Durability to Discovery: Advances in ALK+ mNSCLC Treatment
Project Oncology®From Durability to Discovery: Advances in ALK+ mNSCLC Treatment
Angel Qin, MD
How Novel Strategies Could Push ALK+ mNSCLC Care Forward
Project Oncology®How Novel Strategies Could Push ALK+ mNSCLC Care Forward
Angel Qin, MD
How ALK Vaccines Could Prolong TKI Response in mNSCLC
Project Oncology®How ALK Vaccines Could Prolong TKI Response in mNSCLC
Angel Qin, MD
Patterns of Progression and Resistance in ALK+ mNSCLC
Project Oncology®Patterns of Progression and Resistance in ALK+ mNSCLC
Alice T. Shaw, MD, PhD
Guiding mNSCLC Treatment After ALK-TKI Progression
Project Oncology®Guiding mNSCLC Treatment After ALK-TKI Progression
Alice T. Shaw, MD, PhD
Investigating Unanswered Questions in ALK+ mNSCLC Care
Project Oncology®Investigating Unanswered Questions in ALK+ mNSCLC Care
Alice T. Shaw, MD, PhD
- advertisement
Patient-Centered Care in ALK+ Non-Small Cell Lung Cancer
Project Oncology®Patient-Centered Care in ALK+ Non-Small Cell Lung Cancer
Jorge Nieva, MD
Evolving Treatment Strategies in ALK+ Non-Small Cell Lung Cancer
Project Oncology®Evolving Treatment Strategies in ALK+ Non-Small Cell Lung Cancer
Jorge Nieva, MD
Comprehensive Molecular Testing in ALK+ Non-Small Cell Lung Cancer
Project Oncology®Comprehensive Molecular Testing in ALK+ Non-Small Cell Lung Cancer
Urs Weber, MD
Side Effect Management in ALK+ Non-Small Cell Lung Cancer Care
Project Oncology®Side Effect Management in ALK+ Non-Small Cell Lung Cancer Care
Urs Weber, MD
Beyond ALK Inhibition: Addressing Unmet Needs in Non-Small Cell Lung Cancer
Project Oncology®Beyond ALK Inhibition: Addressing Unmet Needs in Non-Small Cell Lung Cancer
Urs Weber, MD
Building on Progress in ALK+ Non-Small Cell Lung Cancer Treatment
Project Oncology®Building on Progress in ALK+ Non-Small Cell Lung Cancer Treatment
Urs Weber, MD
- advertisement